Evidence map›Paper›PMID 36687643›Full record

ArticleFrontiers in microbiology2022

Spread of the

Michaël Treilles, Pierre Châtre, Antoine Drapeau, Jean-Yves Madec, Marisa Haenni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Public health challenges · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. Global Variation inAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Epidemiology and zoonotic transmission ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michaël TreillesLaboratoire d'Analyse Qualyse, Champdeniers Saint-Denis, France.
Pierre ChâtreUnité Antibiorésistance et Virulence Bactériennes, Agence Nationale de Sécurité Sanitaire (ANSES) - Université de Lyon, Lyon, France.
Antoine DrapeauUnité Antibiorésistance et Virulence Bactériennes, Agence Nationale de Sécurité Sanitaire (ANSES) - Université de Lyon, Lyon, France.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, Agence Nationale de Sécurité Sanitaire (ANSES) - Université de Lyon, Lyon, France.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, Agence Nationale de Sécurité Sanitaire (ANSES) - Université de Lyon, Lyon, France.
Université Claude Bernard Lyon 1 · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRLaboratoire Cognitions Humaine et Artificielle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colistin-resistance widely disseminated in food-producing animals due to decades of colistin use to treat diarrhea. The plasmid-borne Methods: We looked for colistin-resistant isolates presenting plasmid-borne genes of the mcr family in both breeding ( Results: Only the Discussion: Our results show that the

Indexed as

colistingoatIncHI2IncX4mcr-1transmissiontransposon

Identifiers

PMID36687643
PMCPMC9846274
OpenAlexW4313584795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.